0 Commentaires
0 Parts
1KB Vue
0 Aperçu
Rechercher
Découvrez de nouvelles personnes, créer de nouvelles connexions et faire de nouveaux amis
-
Connectez-vous pour aimer, partager et commenter!
-
Manufacturing Hope: How Cell and Gene Therapy Manufacturing Is Advancing with CDMO PartnershipsThe Cell and Gene Therapy CDMO Market is experiencing explosive growth as cell and gene therapy manufacturing continues to advance with strategic CDMO partnerships. According to market reports, the global Cell and Gene Therapy CDMO Market was valued at USD 27.34 billion in 2024 and is projected to reach USD 95.6 billion by 2032, exhibiting an impressive CAGR of 16.94% during the...0 Commentaires 0 Parts 210 Vue 0 Aperçu
-
Transforming Biopharmaceutical Manufacturing Through the Cell and Gene Therapy CDMO MarketThe Cell and Gene Therapy CDMO Market is experiencing rapid transformation, with the market size projected to reach approximately USD 366.93 billion by 2035, highlighting an impressive CAGR of 23.53% from the current valuation of USD 35.89 billion in 2024. This substantial growth can be attributed to the rising demand for personalized medicine and advancements in production technologies. As...0 Commentaires 0 Parts 284 Vue 0 Aperçu
-
Global Biopharmaceutical and Bio-CDMO Market Growing at 14.2% CAGR Through 2032According to a new report from Intel Market Research, the global Biopharmaceutical and Bio-CDMO market was valued at USD 25.71 billion in 2024 and is projected to grow from USD 28.95 billion in 2025 to USD 63.88 billion by 2032, exhibiting a robust CAGR of 14.2% during the forecast period (2025–2032). This growth is driven by increasing demand for biologics and biosimilars due to their...0 Commentaires 0 Parts 1KB Vue 0 Aperçu
-
United States Sterile Fill-Finish for Cell and Gene Therapies Market Growing at 8.9%According to a new report from Intel Market Research, the United States Sterile Fill-Finish for Cell and Gene Therapies Market was valued at USD 0.54 billion in 2025 and is projected to reach USD 1.04 billion by 2034, growing at a robust CAGR of 8.9% during the forecast period (2025–2034). This expansion is driven by accelerating investments in cell‑and‑gene therapy pipelines, supportive...0 Commentaires 0 Parts 1KB Vue 0 Aperçu